PD

Patrick Donnelly Citigroup Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
MTD icon
1
Mettler-Toledo International
MTD
$26.9B
$1,305.71 $1,600
23%
upside
Buy 17 days ago
ICLR icon
2
Icon
ICLR
$13.6B
$174.88 $200
14%
upside
Neutral 17 days ago
TECH icon
3
Bio-Techne
TECH
$8.46B
$54.41 $70
29%
upside
Buy 17 days ago
CAI
4
Caris Life Sciences, Inc. Common Stock
CAI
$9.8B
$34.85 $42
21%
upside
Buy 25 days ago
QDEL icon
5
QuidelOrtho
QDEL
$1.95B
$28.68 $40
39%
upside
Buy 1 month ago
BRKR icon
6
Bruker
BRKR
$4.68B
$30.83 $38
23%
upside
Neutral 1 month ago
CRL icon
7
Charles River Laboratories
CRL
$8.07B
$163.99 $200
22%
upside
Buy 2 months ago
HOLX icon
8
Hologic
HOLX
$14.8B
$66.76 $80
20%
upside
Buy 2 months ago
ILMN icon
9
Illumina
ILMN
$15.7B
$98.93 $80
19%
downside
Sell 2 months ago
BIO icon
10
Bio-Rad Laboratories Class A
BIO
$8B
$295.43 $350
18%
upside
Buy 4 months ago
TXG icon
11
10x Genomics
TXG
$1.74B
$13.96 $15
7%
upside
Buy 6 months ago
AVTR icon
12
Avantor
AVTR
$9.07B
$13.31 $18
35%
upside
Neutral 6 months ago
IQV icon
13
IQVIA
IQV
$31.9B
$187.68 $210
12%
upside
Neutral 6 months ago
TMO icon
14
Thermo Fisher Scientific
TMO
$186B
$492.60 $570
16%
upside
Neutral 6 months ago
DGX icon
15
Quest Diagnostics
DGX
$20.5B
$183.49 $185
1%
upside
Neutral 6 months ago
DHR icon
16
Danaher
DHR
$143B
$200.21 $265
32%
upside
Buy 7 months ago
FTRE icon
17
Fortrea Holdings
FTRE
$1.06B
$11.63 $23
98%
upside
Neutral 9 months ago
SHC icon
18
Sotera Health
SHC
$4.44B
$15.62 $20
28%
upside
Buy 10 months ago
EXAS icon
19
Exact Sciences
EXAS
$10.2B
$53.81 $75
39%
upside
Buy 10 months ago
A icon
20
Agilent Technologies
A
$36.5B
$128.75 $165
28%
upside
Buy 1 year ago
GH icon
21
Guardant Health
GH
$7.5B
$60.13 $45
25%
downside
Buy 1 year ago
STVN icon
22
Stevanato
STVN
$6.59B
$24.15 $28
16%
upside
Buy 1 year ago
RVTY icon
23
Revvity
RVTY
$10.1B
$86.64 $145
67%
upside
Buy 1 year ago
QGEN icon
24
Qiagen
QGEN
$10.3B
$47.55 $61.80
30%
upside
Buy 1 year ago
WAT icon
25
Waters Corp
WAT
$18.2B
$306.32 $300
2%
downside
Neutral 1 year ago